Skip to content
Patients
HCPs
X-twitter Instagram Youtube Icon-mail Tiktok
Follow on X
Home
Daily Updates

Categories

Camrelizumab plus chemotherapy versus chemoradiotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma: Phase 2 randomized trial (REVO).

  • Post category:Digestive (CRC, Stomach) System
  • Reading time:1 min read

This multicenter, randomized phase 2 trial compared neoadjuvant camrelizumab plus chemotherapy (ICT) versus chemoradioth...

Continue ReadingCamrelizumab plus chemotherapy versus chemoradiotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma: Phase 2 randomized trial (REVO).
  • © Together4Cancer. All rights reserved.
  • Privacy Policy
  • Terms of Use